Haemodialysis-associated amyloidosis

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Haemodialysis-associated amyloidosis
SpecialtyEndocrinology Edit this on Wikidata

Haemodialysis-associated amyloidosis is a form of systemic amyloidosis associated with chronic kidney failure.[1]

Presentation[edit]

Long-term haemodialysis results in a gradual accumulation of β2 microglobulin, a serum protein, in the blood.[2] It accumulates because it is unable to cross the dialysis filter.

Affected individuals usually present after 5 years of dialysis rarely before that. The tendency of haemodialysis-associated amyloidosis is to be articular in general affecting the joints.

Diagnosis[edit]

Prevention[edit]

Low copper dialysis is theorized to prevent or delay onset.[3]

Management[edit]

See also[edit]

References[edit]

  1. ^ Miyata T, Oda O, Inagi R, et al. (September 1993). "beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis". J. Clin. Invest. 92 (3): 1243–52. doi:10.1172/JCI116696. PMC 288264. PMID 8376584.
  2. ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
  3. ^ "BU Amyloid Treatment & Research Program". Archived from the original on 2008-07-20.

External links[edit]

Classification
External resources